All-trans retinoic acid (ATRA) was used in a case of acute promyelocyt
ic leukemia (APL) in late pregnancy. A very prompt maternal risk reduc
tion was achieved with subsequent complete remission and spontaneous d
elivery of two live children in whom no fetal damage seems to have occ
urred.